1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
621E485750B8D37EC852569670059B3B7
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/incorporate-advocacy-group-payer-and-employer-influence-on-drug-development?opendocument
18
19opendocument
2018.205.109.82
21
22
23
24/bestp/domrep.nsf
25DB




Products & Services Sales and Marketing New Product Development and Launch Ensuring Market Focus Customer and Thought Leader Involvement

Incorporate Advocacy Group, Payer, and Employer Influence on Drug Development

DB Image

ID: 3626


Features:

Graphics


Words: 601


Published: Pre-2014


Delivery Format: Online


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Incorporate input from non-physician influencers to bring commercially focused
products to market.
Non-physician opinion leaders are playing an ever-greater role in the
pharmaceutical industry, so infusing the drug development process with input
from these influential groups is paramount. While individual consumers have
incremental impacts on pharmaceutical sales, large representative groups have
fundamentally reshaped the landscape, forcing pharma companies to develop a
formal plan for interacting with them. Some specific influences tracked by one
benchmark partner include:
Pricing models are driven by managed care considerations starting in
Phase II. Active involvement with managed care organizations starts in Phase
III. The company has a sales and marketing group specifically dedicated to
addressing managed care concerns ...

Industries Profiled:
Pharmaceutical


Companies Profiled:
A Leading Pharmaceutical Company

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.